Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country

BACKGROUND: The costs associated with the treatment of sickle cell disease (SCD) are understudied in low and middle-income countries (LMIC). We evaluated the cost of treating SCD-related acute complications and the potential cost-savings of hydroxyurea in a specialized hematology center in Brazil. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobo, Clarisse, Moura, Patricia, Fidlarczyk, Delaine, Duran, Jane, Barbosa, Roberto, Oliveira, Thais, do Nascimento, Emilia Matos, Bhakta, Nickhill, Hankins, Jane S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742916/
https://www.ncbi.nlm.nih.gov/pubmed/34998394
http://dx.doi.org/10.1186/s12913-021-07461-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742916/
https://www.ncbi.nlm.nih.gov/pubmed/34998394
http://dx.doi.org/10.1186/s12913-021-07461-6

Ejemplares similares